Task: Answer the multiple choice question.
Query: Which drug exhibits a -17.245% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CCC(=O)n1nc(-c2ccc(Cl)cc2)nc1SC
b) CCC(=O)Nc1ccc2nc(SCC(=O)N3CCOCC3)sc2c1
c) COC(=O)c1cc2oc(C)cc2n1CC(=O)N1CCCc2ccccc21
d) O=C(Nc1cnn(Cc2c(Cl)cccc2Cl)c1)C(c1ccccc1)c1ccccc1
Answer: b. CCC(=O)Nc1ccc2nc(SCC(=O)N3CCOCC3)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc2nc(SCC(=O)N3CCOCC3)sc2c1
CCC(=O)Nc1ccc2nc(SCC(=O)N3CCOCC3)sc2c1
N-[2-(2-morpholin-4-yl-2-oxoethyl)sulfanyl-1,3-benzothiazol-6-yl]propanamide